Huntington Bancshares Incorporated
In the published model solve dated 2026-Q2, anchored at $16.92, Huntington Bancshares Incorporated (HBAN) is priced for 12.0% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed August 7, 2026 from SEC EDGAR filings.
• Two acquisitions in four months rebuilt the company, Veritex closing on October 20, 2025 and Cadence Bank on February 1, 2026, after which ⟦Total assets at June 30, 2026 were $284.0 billion, an increase of $58.9 billion, or 26%, compared to December 31, 2025⟧. • Paying for that scale thinned the cushion that absorbs losses, with the common equity tier 1 ratio falling to 10.0% at June 30, 2026 from 10.4% at the end of 2025, while net charge-offs rose to 0.25% of average loans from 0.20% a year
Is HBAN overvalued? See what's priced in →
1,112 institutional managers reported holding HBAN in 13F filings for the quarter ended 2026-03-31. Together they hold about 90% of the company; the top 10 hold 52%. 164 opened new positions that quarter. Held by Vanguard Group, BlackRock, Wellington Management, among others. On the short side, 78.0M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (3.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
HBAN's share count grew 66.2% over the past five years even with $800.00M spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.62 a share annually. Cash returned over the past three years: $2.51B in dividends and $150.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at HBAN over the trailing three years: 2025: 1 buy totaling $100k; 2026: 10 buys totaling $1.44M. 33 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
HBAN's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-29 | -0.7% | -14.4% |
| 2023-10-28 | -3.7% | +34.7% |
| 2024-02-17 | +1.1% | +3.3% |
| 2024-05-01 | +0.8% | -4.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
HBAN's latest 8-K filings: 2026-07-23 (items 8.01, 9.01); 2026-07-23 (items 2.02, 9.01); 2026-06-25 (items 8.01, 9.01); 2026-06-08 (items 7.01, 9.01); 2026-05-27 (items 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: August 7, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.